AstraZeneca News

U.S. Recommends Pausing Use of J&J COVID Vaccine over Rare Blood Clots

U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to …

AstraZeneca to Publish Full COVID-19 Vaccine Clinical Trial Results on Efficacy

AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publicly criticized the drugmaker for using “outdated information” to show how well the immunization worked. The rare public rebuke marks the latest …

U.S. Oversight Board Questions AstraZeneca’s COVID-19 Vaccine Data

AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once …

EU Threatens to Ban COVID Vaccine Exports to Britain

BRUSSELS – The European Union threatened on Wednesday to ban exports of COVID-19 vaccines to Britain to safeguard scarce doses for its own citizens facing a third wave of the pandemic that would jeopardize plans to restart travel this summer. …

Investor Sues Drugmaker Astrazeneca Over Coronavirus Vaccine Testing Claims

AstraZeneca PLC was sued by a pension fund on behalf of investors who it says suffered losses because of flaws in the company’s testing of its coronavirus vaccine. For much of last year, the Cambridge, England-based pharmaceutical company was touting …

Who’s On the Hook If COVID-19 Vaccines Go Wrong?: Viewpoint

The COVID-19 vaccines are here and distribution has begun. But what if something goes wrong? Whether it’s a loss of income, hefty medical bills or other serious adverse effects from getting a shot, someone has to pick up the tab, …

Insurers Remain Unfazed by Risks of Clinical Trials for COVID-19 Vaccine

The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigor. Yet, while more than …

EU Strikes Low-Cost Deal With AstraZeneca to Pay COVID-19 Vaccine Claims

European governments will pay claims above an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. The deals reflect different strategies by two of …

Limited Liability Protection for Drugmakers Hampers EU Coronavirus Vaccine Deals

The European Union is offering only partial protection to vaccine makers against legal risks from side-effects of their potential COVID-19 shots, European officials said, in a move that is hampering deals and contrasts with U.S. policy. With vaccines being developed …

Lawyers Urge Use of ‘Vaccine Court’ Over U.S. Injury Compensation Fund for Coronavirus

A U.S. government program that compensates people who say they have been harmed by an emergency vaccine has paid out on fewer than 10% of claims, raising questions whether the process should be used to address any potential side effects …